<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The aim of this study was to evaluate the prevalence and clinical significance of caspase-10 mRNA expression in <z:e sem="disease" ids="C0677948" disease_type="Neoplastic Process" abbrv="">stage II colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) was used to analyze caspase-10 expression in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue and corresponding <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa from 120 patients with <z:e sem="disease" ids="C0677948" disease_type="Neoplastic Process" abbrv="">stage II colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Variables were analyzed by Chi-square test or Fisher's exact test </plain></SENT>
<SENT sid="3" pm="."><plain>Survival was evaluated with method of Kaplan-Meier </plain></SENT>
<SENT sid="4" pm="."><plain>Multivariate analysis was performed with Cox's proportional hazards model </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The expression of caspase-10 mRNA was found to be downregulated in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue compared to <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa (P = 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Poorly differentiated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> showed lower <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression than <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> with greater differentiation (P = 0.031) </plain></SENT>
<SENT sid="7" pm="."><plain>Univariate survival curves, estimated using the method of Kaplan-Meier, defined a significant association between caspase-10 expression and both overall survival (P = 0.012) and disease-free survival (P = 0.021) </plain></SENT>
<SENT sid="8" pm="."><plain>A multivariate analysis, performed by Cox's proportional hazards regression model, confirmed that a low caspase-10 expression was the only significant factor to predict poor prognosis in patients with <z:e sem="disease" ids="C0677948" disease_type="Neoplastic Process" abbrv="">stage II colorectal cancer</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Our data indicate that caspase-10 expression, measured by quantitative real-time RT-PCR, is a possible prognostic factor in patients with <z:e sem="disease" ids="C0677948" disease_type="Neoplastic Process" abbrv="">stage II colorectal cancer</z:e> </plain></SENT>
</text></document>